Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients

2015 ◽  
Vol 11 (4) ◽  
pp. 607-615
Author(s):  
Faina Linkov ◽  
Robert P Edwards ◽  
Andrew Althouse ◽  
Jose A Rauh-Hain ◽  
Marcela G Del Carmen ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
High Risk ◽  
Cancer Patients ◽  
Early Stage ◽  
Survival Outcomes ◽  
Early Stage Endometrial Cancer

Defining optimal adjuvant treatment for high-risk early-stage endometrial cancer

2021 ◽  
Vol 162 ◽  
pp. S123-S124
Author(s):  
Olivia Khouri ◽  
Anne Van Arsdale ◽  
Nicole Vilardo ◽  
Divya Gowthaman ◽  
Gregory Gressel ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
High Risk ◽  
Adjuvant Treatment ◽  
Early Stage ◽  
Early Stage Endometrial Cancer

scholarly journals CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence

2017 ◽  
Vol 30 (7) ◽  
pp. 1032-1041 ◽  
Author(s):  
Katherine C Kurnit ◽  
Grace N Kim ◽  
Bryan M Fellman ◽  
Diana L Urbauer ◽  
Gordon B Mills ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cancer Patients ◽  
Early Stage ◽  
Low Grade ◽  
Beta Catenin ◽  
Risk Of Recurrence ◽  
Increased Risk ◽  
Early Stage Endometrial Cancer

Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors

2014 ◽  
Vol 132 (1) ◽  
pp. 50-54 ◽  
Author(s):  
Lisa M. Landrum ◽  
Elizabeth K. Nugent ◽  
Rosemary E. Zuna ◽  
Elizabeth Syzek ◽  
Robert S. Mannel ◽  
...  
Keyword(s):  
Risk Factors ◽  
Endometrial Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Early Stage ◽  
Intermediate Risk ◽  
Vaginal Cuff ◽  
Early Stage Endometrial Cancer

Extrapelvic Sentinel Lymph Nodes in Endometrial Cancer Patients With Unmapped Pelvic Side: A Brief Report

2018 ◽  
Vol 28 (4) ◽  
pp. 700-703 ◽  
Author(s):  
Salih Taşkin ◽  
Duygu Altin ◽  
Yavuz Emre Şükür ◽  
Firat Ortaç
Keyword(s):  
Endometrial Cancer ◽  
Lymph Nodes ◽  
Cancer Patients ◽  
Detection Rate ◽  
Near Infrared ◽  
Early Stage ◽  
Sentinel Lymph Nodes ◽  
Fluorescent Imaging ◽  
Systematic Lymphadenectomy ◽  
Early Stage Endometrial Cancer

ObjectiveThe aim of the study was to evaluate extrapelvic sentinel lymph nodes (SLNs) in clinical early-stage endometrial cancer patients with unmapped pelvic side(s) during fluorescent imaging-based sentinel mapping.Materials and MethodsEligible patients underwent sentinel mapping using cervical injection of indocyanine green and near-infrared florescent imaging compatible endoscopic systems. Pelvic SLNs were identified and resected. If bilateral mapping was not achieved, upper lymph nodes areas including presacral, upper common iliac, and para-aortic caval regions were explored for any SLN. Systematic lymphadenectomy was performed after applying SLN algorithm steps.ResultsIn 24 of 101 patients, bilateral pelvic mapping was not achieved. Bilateral unmapping was seen in 4 of 24 and unilateral pelvic side mapping in 20 of 24 patients. There was no extrapelvic SLN among 4 cases with bilateral pelvic unmapping, whereas 8 (40%) of 20 patients with unilateral pelvic mapping had extrapelvic SLNs. Five of extrapelvic SLNs were in presacral, 2 in upper common iliac, and 1 in paracaval regions.ConclusionsObserving for extrapelvic SLNs in cases with unmapped pelvic side(s) could increase detection rate of SLN mapping in clinical early-stage endometrial cancer.

Sign in / Sign up

Export Citation Format

Share Document